Carey Kimmelstiel Editor

Robert C. Hendel, MD, MACC, FAHA, MASNC, FSCCT is Professor of Medicine and Radiology at the Tulane University School of Medicine. Dr. Hendel received his medical degree with distinction, from George Washington University School of Medicine. He completed his internship and residency in internal medicine at Northwestern University and went on to receive fellowship training in cardiovascular disease at the University of Massachusetts Medical School. After specialized training in nuclear cardiology, he returned to Northwestern University. Later in his career he relocated to the University of Miami Miller School of Medicine and then to the Tulane University School of Medicine, where he served as the Chief of the Section of Cardiology from 2017-2020.  At the national level, Dr. Hendel has served as the President of the American Society of Nuclear Cardiology and as President of the Cardiovascular Council of the Society of Nuclear Medicine. He has also served two terms on the American College of Cardiology’s Board of Trustees. Dr. Hendel has delivered invited lectureships at multiple national meetings, including conferences in more than 25 countries and authored more than 200 papers and book chapters. His areas of research interest include cardiac imaging, patient risk stratification, and pharmacologic stress testing, and quality and appropriateness of cardiovascular procedures.

Carey Kimmelstiel, MD, FACC, FACP, MSCAI  is Director of the Cardiac Catheterization Laboratories and Interventional Cardiology at Tufts Medical Center and is a Professor of Medicine at Tufts University School of Medicine in Boston, MA. He received his MD from the State University of New York, Downstate Medical Center College of Medicine where he stayed on for training in Internal Medicine, including a year as chief resident. He trained in General Cardiology at the University of Massachusetts Medical Center followed by training in Interventional Cardiology and Heart Failure at Tufts Medical Center. His research interests initially were focused on heart failure and subsequently evolved into studying platelet function and adjunctive therapies for coronary intervention and cath lab treatment of hypertrophic cardiomyopathy.  He is the host of an international interventional cardiology blog where he continues to learn from his fellows who he considers to be some of the most talented interventional cardiologists in the world.